May 7th 2024
Following treatment, 17.5% and 13% of patients reported residual depressive and anxiety symptoms.
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Pediatric Atopic Dermatitis: New Treatments and Therapies
June 30th 2022Lawrence Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego and professor of dermatology and pediatrics and vice-chair of the department of dermatology at UC San Diego School of Medicine, discusses new treatments and therapies for pediatric atopic dermatitis.
Atopic Dermatitis: What's Best Treatment Practice?
June 26th 2022Eric Simpson, MD, MCR, director of clinical research and dermatology professor at the Frances J. Storrs medical school at Oregon Health & Science University in Portland, Oregon, explains dives into what 2022 is bringing to the AD space.
Environmental Factors of Atopic Dermatitis
June 24th 2022Eric Simpson, MD, MCR, director of clinical research and dermatology professor at the Frances J. Storrs medical school at Oregon Health & Science University in Portland, Oregon, details the environment factors that could impact atopic dermatitis.
Dupilumab May Benefit Skin Barrier Function in Patients with Atopic Dermatitis
June 4th 2022A poster presented at the current 2022 Fall Clinical Dermatology Conference for PAs & NPs showed normalization of skin barrier function in patients with moderate to severe atopic dermatitis taking dupilumab, according to the investigators.
Refocusing on Venous Thromboembolism and Chronic Inflammatory Skin Diseases
May 18th 2022Patients with chronic inflammatory skin diseases do not have an increased risk of venous thromboembolism (VTE) compared to a matched healthy control cohort. This knowledge can be useful to clinicians when contemplating systemic immunomodulatory therapies in their dermatologic patients.
Climate Change: Making Patients Sick and What to do About it?
May 9th 2022At the 2022 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting, 4 health care professionals spoke of disease states in both women and children caused by climate change, and what physicians can do to mitigate this crisis.
Why to Assume AD Diagnosis in Adults
May 2nd 2022In a presentation at New Wave Dermatology Conference, Matthew Zirwas, MD, delved into why atopic dermatitis (AD) should be the first condition that comes to mind when an adult patient presents with dermatitis, why presentation is different in pediatric and adult patients, and why treating AD is about more than quality of life.
Atopic Dermatitis in Skin of Color
April 24th 2022A breakfast product theater at the 3rd Annual Society of Dermatology Nurse Practitioners Symposium, sponsored by Sanofi and Regeneron Pharmaceuticals, dove into the different manifestation of atopic dermatitis in skin of color and how to better recognize the disease in this patient population.
NP Review: Clinical Implications of Atopic Dermatitis
April 24th 2022In this video interview, Andrew Blauvelt, MD, MBA, dives into the current state of atopic dermatitis treatment from his talk presented at the Annual Society of Dermatology Nurse Practitioners Symposium, held April 22-23, in Nashville, Tennessee.
The Cutaneous Connection: Sleep Disturbances in Older Patients with AD
April 19th 2022Jonathan Silverberg, MD, the associate professor of dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC, joins us to discuss a poster from the December 2021 RAD conference.